
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
Press Coverage

Let’s Correct Misinformation about Compounded Drugs
This article appeared on the Association of Health Care Journalists website on February 24, 2025.
En savoir plusNews

ISMP Announces 2025 Just Culture Scholarship Recipients
Leaders Chosen from Muscogee (Creek) Nation Medical Center, St. Joseph’s Health, Philadelphia FIGHT The Institute for Safe Medication Practices (ISMP) has awarded the 2025 Judy Smetzer Just Cultur...
En savoir plusPress Coverage

Compounded GLP-1s Require Extra Vigilance
This article appeared on the Specialty Pharmacy Continuum website on December 18, 2024.
En savoir plusPress Coverage

Baxter Restarts Some IV Solutions Manufacturing; ISMP Issues Guidance for Imported IV Products
This article appeared on the Pharmacy Practice News website on December 2, 2024.
En savoir plusNews

ISMP Announces 27th Annual Cheers Award Recipients
Awardees Focused on Vaccine Safety, Opioid Management, Technology The Institute for Safe Medication Practices (ISMP) is proud to announce the 27th Annual Cheers Award winners, who have worked to si...
En savoir plusPress Coverage

ISMP Awards Texas System for Vaccine Safety Efforts
This article appeared on the Becker’s Hospital Review website on November 19, 2024.
En savoir plusStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...
En savoir plus
ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
En savoir plus
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
En savoir plus